Data / Form D filings / Braasch Biotech LLC
Braasch Biotech LLC: Form D filing
Braasch Biotech LLC, a biotechnology company in Garretson, SD, filed a Form D with the SEC in 2012. The latest, on April 9, 2012, reports an offering of no set size with nothing sold yet.
Find out what Braasch Biotech LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 421 ROSE AVE, Garretson, SD, 57030
- Phone
- (605) 376-8756
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- South Dakota
- Year incorporated
- 2008
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 505, Rule 506
- SEC identifier (CIK)
- 1546815
The full lists. Form D filings in South Dakota: 87 rows, $5, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 9, 2012 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeralyn Kay Haffer | Executive Officer, Director | |
| Keith Neil Haffer | Executive Officer, Director |
Other biotechnology companies in South Dakota that filed recently
- Immuno Cancer Biotherapeutics, Inc. $75,000 · Oct 15, 2026
Every Form D from the week of Apr 9, 2012 · All recent filings in South Dakota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Braasch Biotech LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.